Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin-17 and interleukin-22 production in mice

Experimental Dermatology
Kaori KanemaruKiyoko Fukami

Abstract

Psoriasis is a chronic inflammatory skin disorder that is accompanied by an imbalance between the proliferation and differentiation of keratinocytes. A number of studies have suggested an association between obesity and severe psoriasis; however, it remains to be clarified whether obesity exacerbates psoriasis. To address this unsolved question, we induced psoriasiform dermatitis in mouse models for obesity. We found that obesity exaggerated the severity of psoriasiform dermatitis induced by topical application of the Toll-like receptor (TLR) 7 agonist, imiquimod. Ear swelling and epidermal hyperplasia were more prominent in the obese mice than in the control mice. When compared to imiquimod-treated control mice, imiquimod-treated obese mice expressed higher levels of psoriasis mediators, interleukin-17A (IL-17A) and IL-22 in the skin. Food intake restriction partially abrogated enhanced ear swelling and cytokine overproduction in obese mice. Furthermore, the obesity environment and imiquimod treatment synergistically induced an IL-17A downstream molecule, regenerating islet-derived 3γ (Reg3γ), which is a critical molecule for psoriatic epidermal hyperplasia. Palmitic acid, one of the fatty acids released by subcutaneous adipoc...Continue Reading

References

Jul 15, 2000·Cell Research·L Huang, C Li
Oct 11, 2002·The New England Journal of Medicine·Peck Y OngDonald Y M Leung
May 6, 2005·The New England Journal of Medicine·Michael P Schön, W-Henning Boehncke
Oct 21, 2006·Journal of the American Academy of Dermatology·Andrea L NeimannJoel M Gelfand
Oct 21, 2006·The Journal of Clinical Investigation·Hang ShiJeffrey S Flier
Oct 6, 2007·The British Journal of Dermatology·S BoehnckeW-H Boehncke
Nov 21, 2007·Clinics in Dermatology·Cristina AlbanesiGiampiero Girolomoni
Jan 25, 2008·Dermatology : International Journal for Clinical and Investigative Dermatology·A D CohenJ Meyerovitch
Feb 26, 2008·The British Journal of Dermatology·Y WangH-D Chen
Jul 22, 2008·The British Journal of Dermatology·A A CermanT Ergun
Sep 9, 2008·Endocrinology and Metabolism Clinics of North America·Guenther Boden
Sep 24, 2008·Dermatology : International Journal for Clinical and Investigative Dermatology·Luigi NaldiRosanna Cuscito
Nov 20, 2008·The British Journal of Dermatology·C JohansenK Kragballe
Dec 17, 2008·Proceedings of the National Academy of Sciences of the United States of America·Shipra VaishnavaLora V Hooper
Mar 27, 2009·The Journal of Investigative Dermatology·Antonella Di CesareFrank O Nestle
Apr 22, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Leslie van der FitsErik Lubberts
Jul 1, 2009·International Journal of Experimental Pathology·Regina HeidenreichKamran Ghoreschi
Nov 26, 2009·Journal of the European Academy of Dermatology and Venereology : JEADV·B GuidaN Balato
Dec 5, 2009·The American Journal of Medicine·Alice B Gottlieb, Frank Dann
Feb 25, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kimiko NakajimaShigetoshi Sano
Mar 18, 2011·Experimental Dermatology·Wolf-Henning BoehnckeBrian Kirby
Jun 24, 2011·The Journal of Investigative Dermatology·Tomonobu Ezure, Satoshi Amano
Aug 13, 2011·The Journal of Investigative Dermatology·Kristen R TaylorJulie M Jameson
Oct 14, 2011·Nature Immunology·Vladimir Ramirez-CarrozziRajita Pappu
Dec 2, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Astrid B Van BelleLaure Dumoutier
Sep 22, 2012·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Eunok ImSang Hoon Rhee
Oct 16, 2012·The Journal of Clinical Investigation·Luigi TortolaManfred Kopf
Jan 8, 2013·Trends in Immunology·Michelle A LowesJames G Krueger
Jan 30, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Andrew JohnstonNicole L Ward
Jun 12, 2013·JAMA Dermatology·Peter JensenLone Skov
Sep 21, 2013·The Journal of Clinical Investigation·Amanda S MacLeodWendy L Havran
Mar 20, 2014·The British Journal of Dermatology·L NaldiUNKNOWN Psoriasis Emilia Romagna Study Group
Dec 3, 2014·Experimental Dermatology·Mona Ståhle

❮ Previous
Next ❯

Citations

Sep 4, 2015·Molecular Nutrition & Food Research·Vasso ApostolopoulosBarbora de Courten
May 24, 2016·European Journal of Immunology·Kristin StelznerAnja Saalbach
Aug 25, 2016·Reviews in Endocrine & Metabolic Disorders·Kerstin Wolk, Robert Sabat
Jul 15, 2017·Journal of Clinical Medicine·Marwa ChehimiAssia Eljaafari
Nov 16, 2018·The Journal of International Medical Research·Fang WangSiwei Chen
Feb 23, 2019·Expert Opinion on Pharmacotherapy·Andrea ChiricozziGiampiero Girolomoni
Feb 26, 2016·Experimental Dermatology·Ilja L KruglikovUwe Wollina
Aug 17, 2019·Frontiers in Immunology·Manfred KunzAnja Saalbach
Jul 19, 2019·Frontiers in Immunology·Yisheng WongKenji Kabashima
Jun 7, 2017·Archives of Dermatological Research·Hanna MyśliwiecIwona Flisiak
May 18, 2020·Current Obesity Reports·Kyriaki ParoutoglouMaria Dalamaga
Oct 4, 2020·Lipids in Health and Disease·Klaudia DopytalskaIrena Walecka
Mar 14, 2021·The Journal of Allergy and Clinical Immunology·Satoshi NakamizoKenji Kabashima
May 28, 2019·Journal of Dermatological Science·Tetsuya Honda, Kenji Kabashima

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.